source
- STAT+: Abridge inks deals with Nvidia and LillyAbridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.STAT · 2mo ago↗ source
- STAT+: A suspicious denial pattern in Medicare AdvantageMajor Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.STAT · 2mo ago↗ source
- STAT+: Novartis doubles down on molecular glue strategySeniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The ReadoutSTAT · 2mo ago↗ source